Company intelligence
Revvity Signals
About Revvity Signals
Revvity Signals Software has more than three decades providing unrivaled support for scientific workflows. Our powerful solutions are used across R&D disciplines from drug discovery to specialty chemicals material development. Now under our comprehensive Signals One, our end-to-end SaaS solution integrates workflows across biology, chemistry and materials new product development to accelerate scientific innovation, and help scientists help each other. In addition, our robust solution, powered by Spotfire®, can revolutionize the clinical trial process. From our internationally recognized flagship ChemDraw® and E-Notebook applications, to our Signals One to our exclusive Spotfire® partnership that brings scientific data analytics to visual life, no scientific company offers a wider range and more powerful suite of scientific solutions than Revvity Signals.
Verified activity
Signals from Revvity Signals
5 published signals
Presence & Recognition
Revvity Signals is hosting an upcoming Clinical Connect event to discuss how an agentic, AI-powered approach can help teams move from static, manually generated listings to more guided, reviewer-controlled oversight.
Reported by Revvity Signals
Presence & Recognition
Revvity Signals is hosting its fourth Nexus User Conference in Mumbai next month.
Reported by Revvity Signals
Presence & Recognition
Revvity Signals is exhibiting at the EFMC-ISMC conference in Basel, Booth #50, to explore how ChemDraw can move discovery workflows from design through decision-making.
Reported by Revvity Signals
Presence & Recognition
Revvity Signals is exhibiting at Lab of the Future Europe to explore how Signals One for Drug Discovery helps unify scientific data and streamline workflows across the R&D lifecycle.
Reported by Revvity Signals
Research & Knowledge
Revvity Signals published an article examining how agentic systems could help scientists navigate complex discovery workflows by bringing together specialized models, data sources, and research tools.
Reported by Margaret Brown